Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: A new approach in the management of severe Rh-immunization

Journal of Obstetrics and Gynaecology Research

Volumn 22, Issue 6, 1996, Pages 561-567

  Deka, Dipika ^a,b   Buckshee, Kamal ^a   Kinra, Geeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DII/41 ^*  (India)

Author keywords

Intrauterine transfusion; Intravenous immunoglobulin; Rh immunization

Indexed keywords

IMMUNOGLOBULIN;

ADJUVANT THERAPY; ANEMIA; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DELIVERY; FEMALE; FETUS BLOOD; FETUS DEATH; FETUS HYDROPS; FETUS MONITORING; GESTATIONAL AGE; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; INTRAVENOUS DRUG ADMINISTRATION; RHESUS IMMUNIZATION;

EID: 0030479236     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1996.tb01071.x     Document Type: Article

References (25)

1. Whitfield CR. Haemolytic disease of the newborn - A continuing problem. In: Chiswick ML, ed. Recent Advances in Perinatal Medicine. Edinburg: Churchill Livingstone, 1983; 95-115
2. Nicolaides KH, Rodeck CH, Mibashan RS. Have liley charts outlived their usefulness? Am J Obstet Gynecol 1986; 155: 90-94
3. Berkowitz RK, Chitkara U, Goldberg JD. Intrauterine intravascular transfusion for severe red blood cell isoimmunization: Ultrasound guided percutaneous approach. Am J Obstet Gynecol 1986; 155: 574-581
4. Chaplin H, Cohen R, Bloomberg G, et al. Pregnancy and idiopathic thrombocytopenic purpura: A prospective study during 6 month gestation and 3 months postpartum. Br J Haematol 1973; 24: 219-229
5. Newland AC. The use and mechanisms of action of IVIG; an update. Br J Haematol 1989; 72: 301-305
6. Berlin G, Selbing A. Rhesus hemolytic disease treated with plasma exchange and high dose I.V. immunoglobulin. XXI Congress of International Society of Haematology, (Abst.) P.F. 132 A-17. XIX Congress of the International Society of Blood Transfusion, Sydney, Australia, 1986
7. Margulies M, Voto LS, Mathel S, Margulies M. High dose intravenous immunoglobulin for treatment of severe Rh alloimmunization. Vox-Sang 1991; 61: 181-189
8. Frigoletto FB, Greene MF, Benacerraf BR, et al. Ultrasonographic fetal surveillance in the management of the isoimmunized pregnancy. N Engl J Med 1986; 315: 430-432
9. Reece EA, Cole SW, Romero R, et al. Ultrasonography versus amniotic fluid spectral analysis: Are they sensitive enough to predict neonatal complications associated with isoimmunization? Obstet Gynecol 1989; 74: 357-360
10. Lenke RR, Persutte WH, Nemes JM. Combined intravascular transfusion and intraperitoneal transfusion for erythroblastosis fetalis. A report of 2 cases. J Reprod Med 1990; 35: 425-428
11. Graham, Pole J, Barr W, Willoughly MLN. Continuous flow plasmapheresis in management of severe Rhesus disease. Br Med J 1977; 1: 1185-1188
12. Frazer ID, Bothamley JE, Bennett MD, Airth GR, Lehane D, McCarthy M, Roberts FM. Intensive antenatal plasmapheresis in severe Rhesus isoimmunization. Lancet 1976; 1: 6-8
13. Berlin G, Selbing A, Ryden G. Rh hemolytic disease treated with high dose IVIG. Lancet (letter) 1985; 1: 1153
14. Yoshida H, Yoshida Y, Tatsumi K, Asoh T. A new therapeutic antibody removal method using antigen positive red cells. Application to M-incorrpatible pregnant woman. Vox-Sang 1982; 3: 35-44
15. Yoshida H, Ito K, Emi N, Kanzaki H, Matsuura S. A new therapeutic antibody removal method using antigen. Positive red cells II. Application to a P-incompatible pregnant woman. Vox-Sang 1984; 47: 216-223
16. Berger M, Cuppo T, Fauci AS. High dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. J Am Med Assoc 1982; 247: 2824
17. Hockel-M, Queisser-LA, Beck T, Zielberg R, et al. The effect of antenatal intravenous immunoglobulin on ascending intrauterine infection after preterm. J Perinat Med 1992; 20: 101-110
18. Katz VL, Thorp JM Jr, Watson WJ, Fowler L, Heine RP. Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibodies. Obstet Gynecol 1990; 76: 986-988
19. Sacher RA, Zuckerman M, Queenan JT, King J. Severe Rh disease: Successful management with intensive plasmapheresis and intravenous gamma globulin. (Abst). Congress of International Society of Blood Transfusion, Sydney, 1986
20. Scott-JR, Branch ADW, Kochenous NK, Ward K. IVIG treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibody and Rh-immunization. Am J Obstet Gynecol 1988; 159: 1055-1056
21. Camara de la C, Arieta R, Gonzalez A, Iglesias E, Omenaca FV. High dose IVIG as the sole prenatal treatment for severe Rh-immunization. N Eng J Med (letter). 1988; 318: 519-520
22. Sacher RA, King JC. Intravenous gamma globulin in pregnancy: A review. Obstet Gynaecol Surv 1988; 44: 25-34
23. Sheth KV, Sediary SA, Lee J. Effectiveness of four intravenous IgG preparations in prevention of phagocytosis of anti Rh(D) coated erythrocyte by mononuclear phagocytes. Vox-Sang 1993; 65: 190-193
24. Buckley RH. Long term use of intravenous immuneglobulin in patients with primary immunodeficiency disease: Inadequacy of current dosage practices and approach to the problem. J Clin Immunol 1982, 2: 15s
25. Smith EL, Hill RL, Lehman IR, White A, Handler P, Lefkowitz RJ. Principles of biochemistry mamalian biochemistry, 7th Ed. Tokyo: Mc Graw-Hill, 1983; 40